In trastuzumab-resistant HER2-positive breast cancer cells, overexpression of FASN was facilitated by Pin1 via regulating EGF signaling pathway to activate the sterol regulatory element-binding protein-1c (SREBP1c) promoter (Yun et al., 2014). Here, FASN is linked to breast carcinoma.